CONGRESS, CONFERENCES & SEMINARS#

2024#

2024 At-risk MASH diagnosis in patients with type 2 diabetes mellitus, Ibon Martínez-Arranz, Marco Arrese, Rebeca Mayo, Itziar Mincholé, María Encarnación Blanco, Patricia Aspichueta, Cristina Alonso, Jesús M Bañales,
American Diabetes Association, June 21-24, 2024.
| ADA 84 | ID: 1326-P |

2024

One‐step non‐invasive diagnosis of metabolic dysfunction associated steatohepatitis and fibrosis in high‐risk population, Rebeca Mayo, Paula Iruzubieta, Itziar Mincholé, Rocío Aller, Luis Ibañez-Samaniego, Javier Ampuero, Javier Abad, Rosa Martín-Mateos, María Teresa Arias-Loste, Agustín Albillos, Rafael Bañares, José Luis Calleja, Manuel Romero-Gomez, Pablo Ortiz, Ibón Martínez-Arranz, Javier Crespo, Annual Scientific Meeting of the Indian National Association for Study of the Liver (INASL 2024), which will be held from 7th to 10th August 2024 at Le Meridien, Kochi. | INASL 2024 | ID: 590 |

2023#

2023 Genetic Algorithms Reveal Potential to Stratify NAFLD Heterogeneity, Ibon Martínez-Arranz, Cristina Alonso, Rebeca Mayo, Ruben Gil-Redondo, Itziar Mincholé, Alejandro Montilla, Óscar Millet, Mazen Noureddin, Shelly C. Lu, Nicholas Davidson and José M Mato, The Liver Meeting 2023, Annual Meeting of the American Association for the Study of Liver Diseases, November 10-14, 2023.
| AASLD 2023 | ID: 2048-A |

2023 At-risk NASH Identification using an algorithm that combines FIB-4 + MASEF (Metabolomics-Advanced Steatohepatitis Fibrosis Score), Mazen Noureddin, Emily Truong, Rebeca Mayo, Ibon Martínez-Arranz, Itziar Mincholé, Jesus M. Banales, Marco Arrese Jimenez, Kenneth Cusi, Maria Teresa Arias, Radan Bruha, Manuel Romero-Gómez, Paula Iruzubieta, Rocio Aller, Javier Ampuero, Jose Luis Calleja, Luis Ibáñezc Samaniego, Patricia Aspichueta, Antonio Marín-Duce, Tatyana Kushner, Pablo Ortiz, Stephen A Harrison, Quentin M. Anstee, Javier Crespo Garcia, José M Mato and Arun Sanyal,
The Liver Meeting 2023, Annual Meeting of the American Association for the Study of Liver Diseases, November 10-14, 2023.
| AASLD 2023 | ID: 2015-A |

2022#

2022 A baseline signature of metabolites involving the gut-liver axis predicts MRI-PDFF response to FASN INhibitor TVB-2640 in NASH patients: results from the FASCINATE-1 study, Rohit Loomba, Marie O’Farrell, Eduardo B. Martins, Katharine Grimmer, Alithea M. Zetter, Cristina Alonso, Ibon Martinez-Arranz, George Kemble, Stephen A. Harrison,
International Liver Congress 2022
| EASL ILC 2022 | ID: 785 |

2022 Metabolic NAFLD subtypes align with cardiovascular and genetic risk factors, Ibon Martínez-Arranz , Chiara Bruzzone, Mazen Noureddin, Rubén Gil-Redondo, Enara Arretxe, Marta Iruarrizaga-Lejarreta, Maider Bizkarguenaga, Itziar Mincholé, David Fernández Ramos, Fernando Lopitz Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Bettina Mittendorf, Laura Izquierdo-Sánchez, Ylenia Pérez Castaño, Vaclav Smid, Jorge Arnold, Marcin Krawczyk, Paula Iruzubieta, Urko M. Marigorta, Martine C. Morrison, Robert Kleemann, Antonio Martín Duce , Liat Hayardeny , Libor Vitek, Radan Bruha, Rocío Aller , Javier Crespo, Manuel Romero Gomez, Jesus Maria Banales, Marco Arrese, Kenneth Cusi, Elisabetta Bugianesi, Samuel Klein, Shelly C. Lu, Quentin Anstee, Oscar Millet, Nicholas O. Davidson, Cristina Alonso, José M. Mato,
International Liver Congress 2022
| EASL ILC 2022 | ID: 1132 |

2022 Influence of pregnancy on NAFLD-associated lipidomic signatures, Tatyana Kushner, Ibon Martinez-Arranz, Marco Arrese, Mazen Noureddin, Pablo Ortiz, Cristina Alonso,
International Liver Congress 2022
| EASL ILC 2022 | ID: 3411 |

2021#

2021 Diagnostic performance of metabolomic test to detect nonalcoholic esteatohepatitis and significant fibrosis in patients at high risk of progressive fatty liver disease, Rebeca Mayo, Paula Iruzubieta, Itziar Mincholé, Rocío Aller, Luis Ibañez-Samaniego, Javier Ampuero, Javier Abad, Rosa Martín-Mateos, María Teresa Arias-Loste, Agustín Albillos, Rafael Bañares, José Luis Calleja, Manuel Romero-Gomez, Pablo Ortiz, Ibon Martínez-Arranz, Javier Crespo,
The Liver Meeting 2021, Annual Meeting of the American Association for the Study of Liver Diseases, November 12-15, 2021.
Hepatology, Volume 74, Number 1 (Suppl) | 949A
| AASLD 2021 | ID: 1593 |

2021 Metabolic Subtypes of Nonalcoholic Fatty Liver Disease Patients Exhibit Distinctive cardiovascular Risk Profiles, Ibon Martínez-Arranz, Chiara Bruzzone, Rubén Gil-Redondo, Enara Arretxe, Marta Iruarrizaga-Lejarreta, Maider Bizkarguenaga, Itziar Mincholé, David Fernández Ramos, Fernando Lopitz Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Martine C. Morrison, Robert Kleemann, Libor Vitek, Radan Bruha, Rocío Aller, Javier Crespo, Manuel Romero Gomez, Jesus Maria Banales, Marco Arrese, Kenneth Cusi, Elisabetta Bugianesi, Samuel Klein, Mazen Noureddin, Shelly C. Lu, Quentin Anstee, Oscar Millet, Nicholas O Davidson, Cristina Alonso, José M. Mato,
The Liver Meeting 2021, Annual Meeting of the American Association for the Study of Liver Diseases, November 12-15, 2021.
Hepatology, Volume 74, Number 1 (Suppl) | 966A
| AASLD 2021 | ID: 1619 |

2021 Non-alcoholic fatty liver disease cardiovascular risk by metabolic subtype, Ibon Martínez-Arranz, Chiara Bruzzone, Rubén Gil-Redondo, Enara Arretxe, Marta Iruarrizaga-Lejarreta, Maider Bizkarguenaga, Itziar Mincholé, David Fernández Ramos, Fernando Lopitz Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Martine C. Morrison, Robert Kleemann, Libor Vitek, Radan Bruha, Rocío Aller, Javier Crespo, Manuel Romero Gomez, Jesus Maria Banales, Marco Arrese, Kenneth Cusi, Elisabetta Bugianesi, Samuel Klein, Mazen Noureddin, Shelly C. Lu, Quentin Anstee, Oscar Millet, Nicholas O Davidson, Cristina Alonso, José M. Mato,
Journal of Hepatology 2021 vol. 75(2) | S294–S803
| EASL ILC 2021 | ID: PO-916 |

2021 Serum metabolomics-based steatohepatitis score for the non-invasive identification of patients with non-alcoholic steatohepatitis (NASH) in multiethnic, including type 2 diabetes mellitus population Pablo Ortiz, Itziar Mincholé, Rebeca Mayo, Ibon Martínez-Arranz, Jesus Maria Banales, Marco Arrese, Javier Crespo, Paula Iruzubieta, Libor Vitek, Radan Bruha, Manuel Romero Gomez, Cristina Alonso, Kenneth Cusi, Mazen Noureddin, José M. Mato, Arun Sanyal,
Journal of Hepatology 2021 vol. 75(2) | S294–S803
| EASL ILC 2021 | ID: PO-1518 |

2021 Metabolomic predictive models in the diagnosis of drug-induced liver injury Daniel E. Di Zeo-Sánchez, M. Robles-Díaz, Ibon Martínez-Arranz, Inmaculada Medina-Caliz, Aida Ortega-Alonso, Miren Garcia Cortes, Jose Pinazo Bandera, J. Sanabria-Cabrera, Enrique del Campo Herrera, Rocio González-Grande, Miguel Jiménez, Maria Isabel Lucena, Raul J. Andrade,
Journal of Hepatology 2021 vol. 75(2) | S294–S803
| EASL ILC 2021 | ID: PO-1335 |

2020#

2020 NAFLD subtypes with impaired VLDL secretion segregate with cardiovascular and cancer risk factors Chiara Bruzzone, Mazen Noureddin, Ibon Martinez-Arranz, Marta Iruarrizaga-Lejarreta, Ruben Gil-Redondo, Elizabeth P Newberry, Enara Arretxe, Maider Bizkarguenaga, Borja Lanza, Nieves Embade, Itziar Mincholé, Rebeca Mayo, David Fernández-Ramos, Fernando Lopitz-Otsoa, Óscar Millet, Nicholas O Davidson, Cristina Alonso, Shelly C Lu, Jose M Mato,
The Liver Meeting 2020, Annual Meeting of the American Association for the Study of Liver Diseases, November 12-15, 2021.
Hepatology, vol. 72, | 1729A | Supplementary
| ID: 1729 |

2020 The serum-based Metabolomics Advanced StEatohepatits Fibrosis Score (MASEF) for the non-invasive identification of patients with NASH and significant fibrosis, M. Noureddin, R. Mayo, I. Martínez-Arranz, I. Mincholé, K. Cusi, F. Bril, J. Banales, M. Arrese, J. Crespo, P. Iruzubieta, L. Valenti, A. Martín-Duce, L. Vitek, R. Bruha, E. Mena, M. Romero-Gómez, C. Alonso, P. Ortiz, J. Dufour, Q. Anstee, J. Mato, A. Sanyal,
The Liver Meeting 2020, Annual Meeting of the American Association for the Study of Liver Diseases, November 12-15, 2021.
Hepatology, vol. 72, | 948A | Supplementary
| ID: 1560 |

2020 Utilidad Clínica de un método no invasivo para el diagnóstico de hígado graso no alcohólico y esteatohepatitis en diabetes tipo 2, Virginia Bellido, Ibon Martínez-Arranz, Antonio J. Amor, Jose Javier Pi, Pedro Gil, Olga González, Sonia Gaztambide,
SED, Sociedad Española de Diabetes, Madrid, Spain, April 22-24, 2020
| web |

2020 Serum metabolic biomarkers for the differential diagnosis of distal cholangiocarcinoma and pancreas ductal adenocarcinoma, Ana Peleteiro Vigil Jesus M. Banales, Maria Laura Gutierrez, Ainhoa Lapitz, Luis Muñoz-Bellvis, Adelaida La Casta, Enara Arretxe, Cristina Alonso, Ibon Martinez-Arranz, Luis M. Gonzalez, Rui E. Castro, Matías A Avila, María Luz Martínez-Chantar, Maria Serrano, Luis Bujanda, Jose Marin, Rocio IR Macias,
Liver Cancer Summit 2020, Prague, Czech Republic, February 6-8, 2020
| web |

2019#

2019 Obese patients carrying NAFLD-associated genetic variants present specific serum and liver lipidomic profiles: Identification of a lipidomic signature in serum to estimate the liver fat content, Alvaro Santos-Laso, Leyre Velaz, Cristina Alonso, Emma Eizaguirre, Ibon Martínez-Arranz, Maria Jesus Pareja, Ioana Riaño, Jesper Andersen, Enara Arretxe, Itziar Mincholé, Pablo Ortiz, Maria Jesus Perugorria, Ana Landa, Marcin Krawczyk, Frank Lammert, Rui Eduardo Castro, Patricia Aspichueta, Manuel Romero-Gomez, Luis Bujanda, Pedro Miguel Rodrigues and Jesus Banales,
The Liver Meeting 2019, The 70th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, (EEUU), November 8-12, 2019.
| AASLD Foundation Abstract Award Recipient | ID: 260 | ima 2019 Non-invasive serum lipidomic approach to discriminate non-alcoholic steatohepatitis in multiethnic patients with type 2 Diabetes Mellitus, Ibon Martínez-Arranz, Rebeca Mayo, Jesus Banales, Itziar Mincholé, Pablo Ortiz, Fermando Bril, Marco Arrese, Javier Crespo Garcia, Cristina Alonso, Jose M. Mato and Kenneth Cusi,
The Liver Meeting 2019, The 70th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, (EEUU), November 8-12, 2019.
| ID: 1714 |

2019 Serum metabolites as diagnostic biomarkers for Cholangiocarcionoma, Hepatocellular Carcinoma and Primary Sclerosing Cholangitis, J.M. Banales, M. Iñarrairaegui, A. Arbelaiz, P. Milkiewicz, J. Muntane A. La Casta, L. Muñoz-Bellvis, L.M. Gonzalez, E. Arretxe, C. Alonso, I. Martínez-Arranz, A. Lapitz, A. Santos-Laso, M.A. Avila, M.L. Martinez-Chantar, L. Bujanda, J.J.G. Marin, B. Sangro, R.I.R. Macias,
The International Liver CongressTM, Vienna, Austria, 10-14 April, 2019.

2018#

2018 Targeted UPLC-MS metabolomic analysis of human faeces reveals novel low-invasive candidate markers for colorectal cancer, Cubiella J., Clos-Garcia M., Alonso C., Martínez-Arranz I., Pérez-Cormenzana M., Cabrera D., Barrenetxea Z., Berganza J., Rodríguez-Llopis I., D'Amato M., Bujanda Fernández de Piérola L., Díaz-Ondina M., Falcón-Pérez J.M.,
UEG Week 2018, Vienna, Austria, October 20-24, 2018.
| web |

2018 Application of a Non-Invasive Integrated Screening Algorithm to Improve Enrollment in NAFLD/NASH Clinical Trials, Gerardo Rodriguez-Araujo, Moises Hernandez, Linda Morrow, Laura Millán, Ibon Martínez-Arranz, Marcus Hompesch,
2nd Annual NASH Summit, Boston, MA, 23-25 April, 2018.
| web |

2018 Targeting the NAFLD metabolome and the shaping of precision medicine for patients with NASH, M. Iruarrizaga-Lejarreta, I. Martínez-Arranz, M.C. Morrison, M. Varela-Rey, D.F. Ramos, L. Delacruz-Villar, M. Noureddin, M.L.Martínez-Chantar, R.Kleemann, C.Alonso, S.C.Lu, J.M.Mato,
The International Liver CongressTM, Paris, France, 11-15 April, 2018.
| web | ID: THU-516 |

2017#

2017 Application of a non-invasive integrated screening approach to facilitate enrollment of clinical trials with investigational NAFLD/NASH therapeutics, Gerardo Rodríguez-Araujo, Moises Hernández, Christian Weyer, Linda Morrow, Laura Millán, Ibon Martínez-Arranz, Marcus Hompesch,
EASL, First NAFLD Summit, Rome, Italy, 09-11 November 2017.
| web | pdf | ID: P03-05 |

2017 Metabolomics approach addresses the heterogeneity of NAFLD and determines subtypes associated with different metabolic alterations, Marta Iruarrizaga-Lejarreta, Marta Varela-Rey, David Fernández-Ramos, Ibon Martínez-Arranz, Laura delaCruz-Villar, Rebeca Mayo, Arantza Peña, Juan Rodríguez-Cuesta, Liat Hayardeny, Mazen Noureddin, Cristina Alonso, Juan Anguita, María Luz Martínez-Chantar, Shelly C Lu, José M Mato,
The Liver Meeting 2017, The 68th Annual Meeting of the American Association for the Study of Liver Diseases, Washington DC, (EEUU), October 20-24, 2017.

2017 Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis (PSC), cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC), Ander Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, Alvaro Santos-Laso, Ainhoa Lapitz, Maria J. Perugorria, Oihane Erice, Esperanza Gonzalez, Raul Jimenez-Agüero, Adelaida Lacasta, Cesar Ibarra, Alberto Sanchez-Campos, Juan P. Jimeno, Frank Lammert, Piotr Milkiewicz, Marco Marzioni, Rocio I.R. Macias, Jose J. G. Marin, Tushar Patel, Gregory J. Gores, Ibon Martinez, Félix Elortza, Juan M. Falcón-Pérez, Luis Bujanda, and Jesus M. Banales,
The Liver Meeting 2017, The 68th Annual Meeting of the American Association for the Study of Liver Diseases, Washington DC, (EEUU), October 20-24, 2017.

2017 A precision medicine approach to comprehensive NAFLD diagnosis through liquid biopsy metabolomics, Ortiz P, Puri P, Martínez-Arranz I, Mincholé I, Idowu M, Arribas J, Lanza B, Dufour J, Mayo R, Romero-Gómez M, Bruha R, Crespo J, Banales J, García-Monzón C, Martín-Duce A, Alonso C, Noureddin M, Bedossa P, Sanyal AJ, Mato JM,
ICFL 2017, 1st International Conference Fatty Liver, Sevilla (Spain), June 1-3, 2017.
| web | ID: ICFL7-0066 |

2017 Beneficts of weight loss and mediterranean diet adherence in the evolution of nonalcoholic fatty liver disease. Utility of noninvasive lipidomic test for diagnosis, Miriam Pérez-Cormenzana, Ibon Martínez-Arranz, María Concepción García, Itziar Mincholé, Natalia Mora, Borja Lanza, David Primo, Beatriz Antolín, Jessica Arribas, Cristina Alonso, Rocío Aller,
ICFL 2017, 1st International Conference Fatty Liver, Sevilla (Spain), June 1-3, 2017.
| web | ID: ICFL7-0069 |

2017 Prevalence of nonalcoholic fatty liver disease (NAFLD) in a healthy adult population, using two lipidomic diagnostic methods, García W, Mayo R, Gil-Aldea I, Cemborain A, Purroy A, Huarte MP, Uriz J, Zozaya JM, Mincholé I, Martínez-Arranz I, Lanza B, Arribas J, Vadillo A, Castro A, Ortiz P,
ICFL 2017, 1st International Conference Fatty Liver, Sevilla (Spain), June 1-3, 2017.
| web | ID: ICFL7-0070 |

2017 Comprehensive NAFLD diagnosis based on a noninvasive metabolomic approach in a liquid biopsy, Puneet Puri, Ibon Martinez-Arranz, Itziar Mincholé, Michael O. Idowu, Rebeca Mayo, Jean-François Dufour, Manuel Romero-Gómez, Radan Bruha, Javier Crespo, Jesus M. Banales, Carmelo García-Monzón, Antonio Martín-Duce, Cristina Alonso, Pablo Ortiz, Mazen Noureddin, Shelly C. Lu, Pierre Bedossa, Arun J. Sanyal, José M. Mato,
The International Liver CongressTM, Amsterdam, the Netherlands, 19-23 April.

2017 Noninvasive serum biomarkers reflect the effect of aramchol on mice fibrotic livers, Marta Iruarrizaga-Lejarreta, Laura delaCruz-Villar, Marta Varela-Rey, Rebeca Mayo, Ibon Martínez-Arranz, David Fernández-Ramos, Liat Hayardeny, Cristina Alonso, Juan Anguita, M. Luz Martínez-Chantar, José M Mato,
The International Liver CongressTM, Amsterdam, the Netherlands, 19-23 April, 2017.

2017 Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma, Ander Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, Alvaro Santos-Laso, Ainhoa Lapitz, Maria J. Perugorria, Oihane Erice, Esperanza Gonzalez, Raul Jimenez-Agüero, Adelaida Lacasta, Cesar Ibarra, Alberto Sanchez-Campos, Juan P. Jimeno, Frank Lammert, Piotr Milkiewicz, Marco Marzioni, Rocio I.R. Macias, Jose J. G. Marin, Tushar Patel, Gregory J. Gores, Ibon Martinez, Félix Elortza, Juan M. Falcón-Pérez, Luis Bujanda, and Jesus M. Banales,
The International Liver CongressTM, Amsterdam, the Netherlands, 19-23 April, 2017.

2017 Metabolomics, Development of Metabolome-based predictors of liver diseases, Cristina Alonso, Enara Arretxe, Marta Iruarrizaga-Lejarreta, Itziar Mincholé, Rubén Gil-Redondo, Ibon Martínez-Arranz,
VALDIG Conference, Ascona (Switzerland), 19-22 February, 2017.
| poster | web |

2017 Diagnóstico y monitorización de hígado graso mediante métodos no invasivos: Correlación entre una nueva huella lipidómica en suero y cantidad de grasa hepática medida por resonancia magnética y por métodos bioquímicos, Raul Jiménez-Agüero, Enara Arretxe, Ibon Martínez-Arranz, Luis Bujanda, Jessica Arribas, Borja Lanza, Maria Jesús Pareja-Megia, Manuel Romero-Gómez, Cristina Alonso, María J Perugorria, Emma Eizaguirre, Marcin Krawczyk, Frank Lammert, Azucena Castro, Jesus M Banales,
42º congreso Anual de la AEHH, Madrid, 15-17 de Febrero de 2017.
| web |

2017 Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma, Ander Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, Alvaro Santos-Laso, Ainhoa Lapitz, Maria J. Perugorria, Oihane Erice, Esperanza Gonzalez, Raul Jimenez-Agüero, Adelaida Lacasta, Cesar Ibarra, Alberto Sanchez-Campos, Juan P. Jimeno, Frank Lammert, Piotr Milkiewicz, Marco Marzioni, Rocio I.R. Macias, Jose J. G. Marin, Tushar Patel, Gregory J. Gores, Ibon Martinez, Félix Elortza, Juan M. Falcón-Pérez, Luis Bujanda, and Jesus M. Banales,
42º congreso Anual de la AEHH, Madrid, 15-17 de Febrero de 2017.
| web |

2016#

2016 OWL Stat App - Una aplicación web para el análisis univariante y multivariante de datos metabolómicos, Ibon Martínez-Arranz, Itziar Mincholé, Maite Gutiérrez-Calzada, Cristina Alonso,
VIII Jornadas de Usuarios de R, Albacete, 17-18 de Noviembre, 2016.
| poster | web |

2016 Metabolomics in a liquid biopsy provides a noninvasive comprehensive NAFLD-diagnostic tool, Cristina Alonso, Puneet Puri, Ibon Martinez-Arranz, Jesús Bañales, Michael O. Idowu, Azucena Castro, Collaborative Group NASH metabolomics, Mazen Noureddin, Pierre Bedossa, José M. Mato, Arun J. Sanyal,
The 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston, MA, United States on November 11-15, 2016.

2016 A non-invasive lipidomic test accurately discriminates NASH from steatosis and tracks evolution of the disease, Miriam Perez-Cormenzana, M Concepción García, Beatriz Antolin, Natalia Mora , Ibon Martinez-Arranz, De luis D. Román, Cristina Alonso, Rocío Aller,
The 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston, MA, United States on November 11-15, 2016.
| web | ABSTRACT FINAL ID: 1108 |

2016 Metabolomic classification of murine and human nonalcoholic fatty liver disease, Cristina Alonso, Jose L. Lavin, Marta Iruarrizaga-Lejarreta, David Fernández, Sebastiaan van Liempd, Laura delaCruz-Villar, Nicolás Navasa, Ibon Martinez-Arranz, Igor Aurrecoechea, Xavier Buqué, Marta Varela, Juan M. Falcon-Perez, Elizabeth P. Newberry, Patricia Aspichueta, Ana M. Aransay, Mazen Noureddin, Juan Anguita, Nicholas O. Davidson, Maria L. Martinez-Chantar, Shelly C. Lu, José Mato,
The 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston, MA, United States on November 11-15, 2016.
| web | ABSTRACT FINAL ID: 1603 |

2016 Translational approach to NASH diversity: learning from mouse models, Cristina Alonso, Marta Iruarrizaga-Lejarreta, Laura delaCruz-Villar, Itziar Mincholé, Ibon Martínez-Arranz, José M Mato,
Translational research in cancer cell metabolism, from 4–6 October 2016 in Bilbao, Spain
| web |

2016 A non-invasive lipidomic test accurately discriminates NASH from steatosis: A blind validation study, Javier Crespo, Ibon Martínez-Arranz, Tim Montgomery, Manuel Romero-Gómez, Rebeca Mayo, Rocío Aller de la Fuente, Joan Caballería, Daniel A. de Luis, Cristina Alonso, Libor Vitek, Radan Bruha, Pablo Ortiz,
1st International Workshop on NASH Biomarkers, 29-30 April 2016, Washington, DC, USA
| web |

2016 Clinical validation of non-invasive lipidomic test for the diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD), Patricia Salvador, Sonia Blanco, Nahikari Maria Irazabal-Remuiñan, Ibon Martínez-Arranz, Luis Francisco Eraña-Ledesma, Itziar Mincholé, Fernando Menéndez, Rebeca Mayo, Pablo Ruiz, Raquel González-Monasterio, Elvira Delgado, Juan Ignacio Arenas, Maider Martos, Antxon Otegui, Gixane Arregui, María Carmen Eizmendi, Sagrario Urquiola, Ricardo San Vicente, Azucena Castro, Pablo Ortiz, Jose Ignacio Pijoán, Javier Bustamante,
EASL, European Association for the Study of the Liver 2016, Barcelona, April 13-17, 2016.
| poster |

2016 A non-invasive lipidomic test accurately discriminates NASH from steatosis: A blind validation study, Javier Crespo, Ibon Martínez-Arranz, Manuel Romero-Gómez, Rebeca Mayo, Rocío Aller de la Fuente, Joan Caballería, Cristina Alonso, Libor Vitek, Pablo Ortiz, Radan Bruha,
EASL, European Association for the Study of the Liver 2016, Barcelona, April 13-17, 2016.

2016 Validación del test OWLiver de segunda generación, un test lipidómico no invasivo para el seguimiento de la enfermedad de higado graso, María Teresa Arias-Loste, Paula Iruzubieta, Antonio Cuadrado, Emilio Fábrega, Ibon Martínez-Arranz, Azucena Castro, Will García, Javier Crespo,
41º Congreso Anual de la AEHH, Madrid, 17-19 de Febrero de 2016.

2016 Evaluación prospectiva en ciego del test lipidómico OWLiver como diagnóstico de enfermedad hepática grasa no alcohólica, R., Aller, C. Alonso, Ibon Martínez-Arranz, MC., García, E., Berroa, C. Tafur, N., Mora, G. González, S. Lorenzo, DA., de Luis,
41º Congreso Anual de la AEHH, Madrid, 17-19 de Febrero de 2016.

2016 A novel non-invasive lipidomic test for the diagnosis and follow-up of NAFLD patients, R. González-Monasterio, P. Salvador, Ibon Martínez-Arranz, N.M. Irazabal-Remuiñan, L.F. Eraña-Ledesma, I. Mincholé, S. Blanco, P. Ruiz, F. Menéndez, R. Mayo, Will García, E. Delgado, J.I. Arenas, M. Martos, A. Otegui, G. Arregi, M.C., Eizmendi, S. Urquiola, R. San Vicente, A. Castro, P. Ortiz, J.I. Pijoán, J. Bustamante,
XXV Congrés de la Societat Catalana de Digestologia, Reus, 30 de Enero, 2016.

2015#

2015 Subtyping nonalcoholic steatohepatitis for the development of effective treatments, Ibon Martínez-Arranz, Cristina Alonso, David Fernández, Rebeca Mayo, Marta Varela, Mazen Noureddin, Maria L. Martinez-Chantar, Shelly C. Lu, Azucena Castro, Jose M. Mato,
The Liver Meeting 2015, The 66th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA (EEUU), November 13-17, 2015., Hepatology, Volume 62, Number 1 (Suppl) -- October 2015, Pages 93A--207A.
| doi |

2015 S-Adenosylmethionine Treatment Corrects Deregulated Lipid Metabolic Pathways and Prevents Progression of Non-Alcoholic Steatohepatitis in Methionine Adenosyltransferase 1a Knockout Mice, David Fernández, Cristina Alonso, Sebastiaan van Liempd, Marta Varela, Nicolás Navasa, Ibon Martínez-Arranz, Patricia Aspichueta, Ana M. Aransay, Juan Anguita, Juan M. Falcón-Perez, M aria L. Martinez-Chantar, Shelly C. Lu, Jose M. Mato,
The Liver Meeting 2015, The 66th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA (EEUU), November 13-17, 2015., Hepatology, Volume 62, Number 1 (Suppl) -- October 2015, Pages 93A--207A.
| doi |

2015 The lipidomic signature of disease progression in nonalcoholic fatty liver disease (NAFLD), Cristina Alonso, Amon Asgharpour, Ibon Martínez-Arranz, Puneet Puri, Mohammad S. Siddiqui, Pablo Ortiz, Jose M. Mato, Arun J. Sanyal,
The Liver Meeting 2015, The 66th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA (EEUU), November 13-17, 2015.,
Hepatology, Volume 62, Number 1 (Suppl) -- October 2015, Page 1262A.
| poster |

2015 The metabolic structure of nonalcoholic steatohepatitis, Cristina Alonso, David Fernandez-Ramos, Ibon Martínez-Arranz, David Balgoma, Sebastiaan M van Liempd, Mazen Noureddin, Patricia Aspichueta, M Luz Martínez-Chantar, Shelly C Lu, José M Mato,
Metabolomics 2015, Burlingame, San Franscisco Bay, CA (EEUU), June 29-July 2, 2015.
| web |

2015 OWL Stat App - An interactive web-application for univariate and multivariate metabolomics data analysis, Ibon Martínez-Arranz, Maite Gutiérrez-Calzada, David Balgoma, Cristina Alonso,
Metabolomics 2015, Burlingame, San Franscisco Bay, CA, June 29-July 2, 2015.
| poster | web |

2015 OWL Stat App - An interactive web-application for univariate and multivariate metabolomics data analysis, Ibon Martínez-Arranz, Maite Gutiérrez-Calzada, David Balgoma, Cristina Alonso,
Science+, Encuentro para estudiantes y profesionales de la Ciencia, Bilbao, 7-9 de Mayo de 2015.

2015 Lipidomic signature linked to alcoholic hepatitis: characterization of ether-linked glycerophospholipids, Cristina Alonso, Javier Michelena, Ainara Cano, Jose Altamirano, Ibon Martínez-Arranz, David Balgoma, Ramón Bataller, Jose M. Mato, Juan Caballería,
Science+, Encuentro para estudiantes y profesionales de la Ciencia, Bilbao, 7-9 de Mayo de 2015.

2015 Identification of serum metabolites associated with cholestatic pruritus, Albert Parés, David Balgoma, Anna Reig, Ibon Martínez-Arranz, Azucena Castro, Antoni Mas,
EASL, European Association for the Study of the Liver 2015, Vienna, Abril de 2015.
Journal of Hepatology, Volume 62, S787--S788.

2015 A metabolic definition of NASH and its resolution by S-Adenosylmethionine in Mat1a KO mice, José M Mato, David Fernandez-Ramos, Ibon Martínez-Arranz, Rebeca Mayo, Sebastiaan M van Liempd, Holger Sann, Julian Platon, Mazen Noureddin, Patricia Aspichueta, Cristina Alonso, M Luz Martínez-Chantar, Shelly C Lu, EASL, European Association for the Study of the Liver 2015, Vienna, Abril de 2015.
Journal of Hepatology, Volume 62, Page S717.
| doi |

2015 A metabolic definition of NASH and its resolution by S-Adenosylmethionine in Mat1a KO mice, David Fernandez-Ramos, Ibon Martínez-Arranz, Rebeca Mayo, Sebastiaan M van Liempd, Holger Sann, Julian Platon, Mazen Noureddin, Patricia Aspichueta, Cristina Alonso, M Luz Martínez-Chantar, Shelly C Lu, José M Mato,
Liver Metabolism and Nonalcoholic Fatty Liver Disease, Whistler, British Columbia, Canada, Marzo de 2015.

2015 Incidence of non-alcoholic fatty liver disease in non-obese and non-diabetic individuals during normal aging, Pablo Ortiz, Rebeca mayo, Miriam Pérez-Cormenzana, Ibon Martínez-Arranz, M.L. Martínez-Chantar, S.C. Lu, J.M. Mato,
Industry Colloquium: Novel Targets and Therapies in Liver Disease, Durham, North Carolina, March 20-21, 2015.
| poster |

2014#

2014 Lipidomic signature linked to alcoholic hepatitis: characterization of ether-linked glycerophospholipids, Cristina Alonso, Javier Michelena, Ainara Cano, Jose Altamirano, Ibon Martínez-Arranz, David Balgoma, Ramón Bataller, Jose M. Mato, Juan Caballería,
Metabomeeting 2014, London, Septiembre de 2014.
| poster |

2014 Deciphering non alcoholic fatty-liver disease lipidomic fluxes, Ainara Cano, Cristina Alonso, Miriam Pérez-Cormenzana, Rebeca Mayo, Ibon Martínez-Arranz, Azucena Castro,
Biochemical Society, Advancing Molecular Bioscience, Abruzzo (Italy), Mayo de 2014.
| abstract | web | Reference ID: P010 |

2014 The adipogenic lipidome of obese rat offspring is reversed by slow digesting carbohydrate diets during pregnancy. NIGOhealth study, López-Pedrosa J.-M., Manzano M., Martin M.-J., Bueno P., Cano A., Castro A., Mayo R., Martinez I., Rueda R.,
International Conference on Developmental Origins of Adiposity and Long-term Health, Munich (Alemania), Marzo de 2014.
| web |

2013#

2013 The signature biomarkers serum lipids of alcoholic steatohepatitis, Cristina Alonso, Javier Michelena, Ibon Martinez-Arranz, Jose Altamirano, Rebeca Mayo, Ramón Bataller, Jose M. Mato, Juan Caballería,
The Liver Meeting 2013, The 64nd Annual Meeting of the American Association for the Study of Liver Diseases, Washington (EEUU), Noviembre de 2013.

2013 El exceso de S-adenosilmetionina deriva la fosfatidiletanolamina hacia la síntesis de fosfatidilcolina y de triglicéridos, Maite Martínez Uña, Marta Varela-Rey, Ainara Cano, Larraitz Fernández-Ares, Naiara Beraza, Igor Aurrekoetxea, Ibon Martínez-Arranz, Juan L García-Rodríguez, Xabier Buqué, Daniela Mestre, Zigmund Luka, Conrad Wagner, Cristina Alonso, Richard H Finnell, Shelly C Lu, M Luz Martínez-Chantar, Jose M Mato, Patricia Aspichueta,
XXXVI Congreso de la Sociedad Española de Bioquímica y Biología Molecular, Madrid, Septiembre de 2013.

2013 Signature lipid biomarker analisis of non-alcoholic liver disease, Cristina Alonso, Ibon Martínez-Arranz, Rebeca Mayo, Miriam Pérez-Cormenzana, Ainara Cano, Joan Caballería, Azucena Castro,
9th Annual Conference of the Metabolomics Society, Glasgow (Scotland), Julio de 2013.
| poster |

2012#

2012 Metabolic profile associated with alcoholic hepatitis and the response to treatment. Preliminary results, Javier Michelena, Cristina Alonso, José Altamirano, Ibon Martínez-Arranz, Ramón Bataller, MariaLuz Martínez-Chantar, Azucena Castro, Jose M. Mato, Juan Caballería,
The Liver Meeting 2012, The 63nd Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts (EEUU), Noviembre de 2012.
| Reference ID: 1363 |

2012 Lipidomic Profiling of Dried Serum Spots (DSS), Mayo, R., Martínez-Arranz, I., Ispizua, Z., Alonso, C., Tandrón, Y., Pérez-Cormenzana, M.,
2nd Metabolomics & Proteomics Workshop 2012, CIC bioGune, Bilbao, Spain, October, 1-3rd 2012, Bilbao (España), Octubre 2012.
| poster |

2012 Software Tools for UPLC-MS Metabolomics, Mincholé, I., Martínez-Arranz, I., Falcón, JM., Tandrón, Y.,
2nd Metabolomics & Proteomics Workshop 2012, CIC bioGune, Bilbao, Spain, October, 1-3rd 2012, Bilbao (España), Octubre 2012.
| poster |

2012 Lipidomic Profiling of Dried Serum Spots (DSS), Mayo, R., Martínez-Arranz, I., Ispizua, Z., Alonso, C., Tandrón, Y., Pérez-Cormenzana, M.,
Metabomeeting 2012, Manchester (UK), Septiembre 2012.
| poster |

2012 Utilidad de la metabolómica para establecer la gravedad y predecir la respuesta al tratamiento en la hepatitis alcohólica. Resultados preliminares, Michelena, J., Alonso, C., Barr, J., Altamirano, J., Martínez-Arranz, I., Bataller, R., Martínez Chantar, M.L., Castro, A., Mato, J.M., Caballería, J.,
XXXVII Congreso Anual de la Asociación Española para el Estudio del Hígado (AEEH), Madrid (España), Febrero 2012.

2012 Perfiles metabólicos dependientes de la obesidad asociados a la progresión del hígado graso no alcohólico, Barr, J., Caballería, J., Martínez-Arranz, I., Domínguez-Díez, A., Muntané, J., Pérez-Cormenzana, M., García-Monzón, C., Mayo, R., Martín-Duce, A., Romero-Gómez, M., Lo Iacono, O., Clément, K., Andrade, R., Pérez-Carreras, M., Gual, P., Fernández-Escalante, C., Arévalo, E., García-Unzueta, M.T., Tordjman, J., Crespo, J., le Marchand Brustel, Y., Gómez Fleitas, M., Martínez Chantar, M.L., Castro, A., S.C. Lu, Alonso, C., Vázquez Chantada, M., Mato, J.M.,
XXXVII Congreso Anual de la Asociación Española para el Estudio del Hígado (AEEH), Madrid (España), Febrero 2012.

2011#

2011 The development of metabolome-based predictors of nonalcoholic fatty liver disease, Barr, J., Caballería, J., Martínez Arranz, I., Domínguez Díez, A., Alonso, C., Muntané, J., Pérez Cormenzana, M., García Monzón, C., Mayo, R., Martín Duce, A., Romero Gómez, M., Lo Iacono, O., Tordjman, J., Andrade, R.J., Pérez Carreras, M., le Marchand Brustel, Y., Tran, A., Fernández Escalante, C., Arévalo, E., García Unzueta, M., Clement, K., Crespo, J., Gual, P.,Gómez Fleitas, M., Martínez Chantar, M.L., Castro, A., S.C. Lu, Vázquez Chantada, M., Mato, J.M.,
7th Annual Advances in Metabolic Profiling conference and exhibition, Dublin (Ireland), Noviembre de 2011.
| poster | Poster Award Winner |

2011 Metabolic profiling as noninvasive tool for nonalcoholic steatohepatitis diagnosis, Barr, J., Caballería, J., Martínez Arranz, I., Domínguez Díez, A., Alonso, C., Muntané, J., Pérez Cormenzana, M., García Monzón, C., Mayo, R., Martín Duce, A., Romero Gómez, M., Lo Iacono, O., Tordjman, J., Andrade, R.J., Pérez Carreras, M., le Marchand Brustel, Y., Tran, A., Fernández Escalante, C., Arévalo, E., García Unzueta, M., Clement, K., Crespo, J., Gual, P.,Gómez Fleitas, M., Martínez Chantar, M.L., Castro, A., S.C. Lu, Vázquez Chantada, M., Mato, J.M.,
The Liver Meeting 2011, The 62nd Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco (EEUU), Noviembre de 2011.
| poster |

2011 Utilización de donantes añosos en el trasplante renal, García-Olaverri Rodríguez, J., Elorrieta, P., Esnaola, K., Rodríguez, P., Marrón, I., Uriarte, I., Martínez-Arranz, I., Aranzabal, J., Moratalla Basante, A., Zabala Egurrola, J.A., Pertusa Peña, C.,
XXV Reunión del Grupo de Trasplante, Córdoba (España), Marzo de 2011.

2011 Trasplante Renal con Donantes añosos (>65 años): Experiencia de 6 años, Elorrieta, P., Esnaola, K., Gainza, F.J., Zabala, A., Rodríguez, P., Marrón, I., Uriarte, I., Martínez-Arranz, I., Pertusa, C., Aranzabal, J.,
XXV Reunión del Grupo de Trasplante, Córdoba (España), Marzo de 2011.

2010#

2010 Utilidad de la Unidad de Información de pacientes renales del País Vasco (UNIPAR), Magaz Lago, A., Aranzabal Pérez, J., Martínez-Arranz, I., Saracho Rotaeche, R., Aguirre, R., Ariceta Iraola, G., Argoitia Urresti, A., Maza, A., Minguela Pesquera, I., Rodrigo de Tomás, M.T.,
XL Congreso Nacional de la Sociedad Española de Nefrología, Granada (España), Octubre de 2010.
| web | web |

2009#

2009 Impacto del fracaso del injerto y el retrasplante en la supervivencia de diálisis, Saracho Rotaeche, R., Moina Eguren, I., Montenegro Martínez, J., Inza, A., Iribar, I., Maza, A., Celayeta, A., Olivar, E., Gimeno, I., Magaz lago, A., Martínez-Arranz, I.,
XXXIX Congreso Nacional de la Sociedad Española de Nefrología, Pamplona (España), Octubre de 2009.
| web | web |

2009 Supervivencia de pacientes en diálisis tras la pérdida del primer injerto. Comparativa con pacientes que inician diálisis sin trasplante previo. Experiencia en el País Vasco, Rodrigo de Tomás, M.T., Porto, M., Lampreabe Gaztelu, I., García Erauzkin, G., Saracho Rotaeche, R., Magaz Lago, A., Martínez-Arranz, I., Aguirre, R., Argoitia Urresti, A., Ariceta Iraola, G., Ruiz de Gauna, R., Maza, A., Moina Eguren, I., Viana Apraiz, F.,
XXXIX Congreso Nacional de la Sociedad Española de Nefrología, Pamplona (España), Octubre de 2009.
| web | web |

2009 New test set to assess Logical Intelligence: CERVANTES, Magaz Lago, A., García Pérez, E.M., Martínez-Arranz, I., Sarrionandia-Ibarra, L.,
10th European Conference on Psychological Assessment, Ghent (Bélgica), Septiembre de 2009.

2008#

2008 Trasplante Renal con Donantes Mayores de 65 años, F.J. Gainza, J. Aranzabal, S. Zárraga, G. García Erauzki, I. Martínez-Arranz, A. Magaz,
XXXVIII Congreso de la Sociedad Española de Nefrología, San Sebastián, Octubre de 2008.
| web |

2008 Explanation model of the evolution of the End-Stage Renal Disease (ESRD) in the Basque Country, 1991-2002, Saracho Rotaeche, R., Rodrigo de Tomás, M.T., Argoitia Urresti, A., Moina Eguren, I., Viana Apraiz, F., García Erauzkin, G., Aguirre, R., Maza, A., Martínez-Arranz, I., Magaz Lago, A.,
XLV ERA-EDTA Congress, Estocolmo (Suecia), Mayo de 2008.

2007#

2007 Do the differences in prevalence of hipertension and diabetes justify the regional differences of ESRD?, Moina Eguren, I., Arrieta Lezama, J., Rodrigo de Tomás, M.T., Saracho Rotaeche, R., García Erauzkin, G., Argoitia Urresti, A., Maza, A., Gimeno, I., Viana Apraiz, F., Aguirre, R., Martínez Arranz, I., Magaz Lago, A.,
XLIV ERA-EDTA Congress, Barcelona (España), Junio de 2007.

2006#

2006 Prevalencia de la IRC en la edad pediátrica en Euskadi. Informe preliminar, Ariceta Iraola, G., Aguirre, M., Areses, R., Orive, B., Sánchez, M.C., Martínez-Arranz, I., Magaz Lago, A.,
XXXII Congreso Nacional de Nefrología Pediátrica, Oviedo (España), Noviembre de 2006.

2004#

2004 Influencia de las características del donante en la funcionalidad del injerto renal a medio y largo plazo, Pérez Beltrán, M.R., Moina Eguren, I., Martínez-Arranz, I., Corral Carames, F., Zárraga Larrondo, S., Magaz Lago, A., Aranzabal Pérez, J., Arrieta Lezama, J.,
XIX Reunión Nacional e Iberoamericana de Coordinadores de Trasplantes, Tenerife (España), Mayo de 2004.

2004 Depresión y supervivencia en enfermos renales crónicos, Magaz Lago, A., Bragado, C., Arrieta Lezama, J., Aranzabal Pérez, J., Martínez-Arranz, I.,
XIII Congreso de Nefrología e Hipertensión de Latinoamérica, Punta del este (Uruguay), Abril de 2004.